At INITIO CELL, we develop patented multi-functional organ-on-a-chip devices and assays for drug discovery and diagnostics.
PRECISION MEDICINE
Classical drug discovery uses 2D cell culture coupled with animal testing for preclinical studies. Neither 2D cell culture nor animal testing truly recapitulate the in vivo micro environments of cells in a human body. The paradigm shift is to use 3D cell culture in organ-on-a- chip devices that can faithfully mimic the in vivo conditions. Using organ-on- chip technology is expected to reduce R&D costs (186 B $ in 2020) by 26%.
WHY CHOOSE INITIO CELL PRODUCTS ?
By Initio Cell
BYOME LABS is a French startup specializing in microbiome testing and analysis. Our mission is…
Welcome to this 33rd edition of ZOOM, a magazine dedicated to preclinical trials and clinical…
Precision and reliability are essential in dermatology and aesthetics. The Antera 3D CS by Miravex…